Rocco, how would you describe the state of the sector?

You know, I, I think that what we've seen in the last few years, especially starting 2020, at least in Italy, we've been hit by-- hard by COVID, is that, uh, you know, there has been a, a constant wave of, of new shocks that we've seen.

And, uh, the result is that we are all probably not going back to the, the, the normal that was before.

So we need to be able to read the reality that we're living into, and at the end of the line, there is always a patient, there is always a, a professional that needs to prescribe a medicine, and the duty and the responsibility of the pharmaceutical company is to make that possible through CDMOs whenever the CDMO is the, is the company, uh, you know, selected, right? So, uh, I think that all this, what happened in the last six years is a source of, an immense source of learning for of all of us.

So we've seen skyrocketing the price of oil and gas.

We've seen, uh, you know, increasingly long lead times for critical materials.

We've seen very, very hard to find capabilities explicitly.

And so how do you guys plan given this kind of uncertain world that we're living in right now?